Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
F
Details...
Enter Symbol
ACORDA THERAPEUTICS (NASDAQ: ACOR)
Sector: Medical
Current Price :
$22.66
52 Week Low
$18.71
52 Week High
$33.08
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
39M
Market Cap:
$0.96B
Avg Volume:
398571
P/E Ratio:
16.970
PEG Ratio:
1.410
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
Earning Scan: ACOR, AES, WIN, POM, WCRX, NST, ATAI, ANV
Nov 04, 2011 12:11 PM |
ACOR
,
AES
,
ATAI
,
NST
,
POM
,
WCRX
U.S. Market To Remain Volatile; Hot Stocks Of The Day: JNJ, AIG
Nov 04, 2011 09:01 AM |
ACOR
,
AIG
,
CME
,
JNJ
,
MHP
,
POM
Earning Scan: AWI, TGE, L, ACOR, ALGN, DEPO
Aug 01, 2011 10:34 AM |
ACOR
,
ALGN
,
AWI
,
DEPO
,
TGE
Stocks Set For Lower Course Initially
May 20, 2011 09:26 AM |
ACOR
,
ANN
,
BKS
,
GPS
Bearish Options Traders Take To Caterpillar Put Options
May 16, 2011 01:43 PM |
ACOR
,
AXL
,
CAT
,
KONG
More Articles on ACOR..
Market News
Survey: Trouble walking hardest part of MS
Oct 23, 2011 10:20 PM |
ACOR
,
HPOL
US Court rules against Acorda in patent litigation against Apotex
Sep 08, 2011 10:43 AM |
ACOR
Acorda receives US patent for use of sustained release Aminopyridine in MS
Aug 11, 2011 10:44 AM |
ACOR
Acorda Therapeutics announces US patent for multiple sclerosis drug
Apr 20, 2011 06:53 AM |
ACOR
GE, Google and Vivus are big market movers
Jan 21, 2011 06:55 PM |
ACOR
,
GE
,
GOOG
,
GS
,
ISRG
,
PEIX
More News on ACOR..
Press Releases
2012 Economic Outlook - Report Highlights Acorda Therapeutics Inc and Pharmacyclics, Inc.
May 17, 2012 09:00 AM |
ACOR
,
PCYC
Acorda Therapeutics to Host Conference Call to Discuss First Quarter 2012 Financial Results on May 3, 2012
Apr 26, 2012 06:00 AM |
ACOR
Acorda Therapeutics Presents AMPYRA? Long-Term Safety and Efficacy Data at 64th American Academy of Neurology Annual Meeting
Apr 25, 2012 07:00 AM |
ACOR
More Press Releases on ACOR..
SEC Filings
Form 4 ACORDA THERAPEUTICS INC For: Mar 15 Filed by: Wasman Jane (10K)
Mar 19, 2012 04:24 PM
Form 4 ACORDA THERAPEUTICS INC For: Mar 15 Filed by: LAWRENCE DAVID (10K)
Mar 19, 2012 04:21 PM
Form 4 ACORDA THERAPEUTICS INC For: Mar 15 Filed by: Sabella Lauren M (10K)
Mar 19, 2012 04:21 PM
More SEC Filings on ACOR..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
ACOR
Compare to S&P
YTD
1.76 %
-9.38 %
4 Weeks
-2.88 %
-1.99 %
12 Weeks
-8.31 %
-9.51 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-40.63 %
EPS Growth in Last Year:
1,050.00 %
Sales Growth in Last Quarter:
-1.92 %
Sales Growth in Last Quarter:
16.25 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##